genomic retroviral elements
Showing 1 - 25 of 2,498
Kidney Cancer Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (cell infusion)
Recruiting
- Kidney Cancer
- cell infusion
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 2, 2022
Breast Carcinoma, Colorectal Carcinoma, Lung Carcinoma Trial in Duarte (Best Practice, Educational Intervention, Genomic
Recruiting
- Breast Carcinoma
- +6 more
- Best Practice
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 11, 2022
Patient and Healthcare Professional Views on Genetic/Genomic
Active, not recruiting
- Hypogonadism, Hypogonadotropic
- Kallmann Syndrome
-
Boston, Massachusetts
- +1 more
Jul 19, 2022
Inflammation, Cardiovascular Diseases, Zinc Deficiency Trial in Cleveland (Zinc Gluconate, Placebo)
Recruiting
- Inflammation
- +2 more
- Zinc Gluconate
- Placebo
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center
Jan 8, 2023
Epiction of Genomic and Genetic Landscape Identifies CCL5
Completed
- Colorectal Neuroendocrine Carcinomas (CRNEC); Genomic Landscape; Genetic Landscape; Prognosis; CCL5; PAX5
- (no location specified)
Jan 27, 2023
Coronary Artery Disease, Atrial Fibrillation, Type 2 Diabetes Trial in Boston (Polygenic risk score (PRS))
Recruiting
- Coronary Artery Disease
- +5 more
- Polygenic risk score (PRS)
-
Boston, MassachusettsVA Boston Healthcare System
Sep 29, 2022
Frequency of Symptomatic Herpes Virus I and II in HIV Infected
Recruiting
- HIV Disease
- +2 more
- Blood draw
-
Los Angeles, CaliforniaGlobal Research Institute
Apr 9, 2023
GenoMed4ALL: Improving SCD Classification and Prognosis by AI
Recruiting
- Sickle Cell Disorders
-
Créteil, France
- +4 more
Aug 24, 2023
Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC
Recruiting
- Non-small Cell Lung Cancer
-
Guanzhou, ChinaSun Yat-sen University Cancer Center
Aug 11, 2023
Exceptional Responders With Pancreatic Cancer to Chemotherapy
Enrolling by invitation
- Solid Tumor Neoplasms
- Standard of Care Chemotherapy
-
Los Angeles, CaliforniaThe Pancreatic Cancer Treatment Center of Los Angeles
Jan 30, 2023
Return of Actionable Variants Empirical Study
Completed
- Familial Hypercholesterolemia
- (no location specified)
Sep 26, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (Best Practice, Chart
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +3 more
- Best Practice
- +6 more
- (no location specified)
Jul 12, 2022
COGNITION: Genomics-Guided Precision Oncology in Early High-Risk
Recruiting
- Early-Stage Breast Cancer
- Neoadjuvant Therapy
- Genomic Profiling / Sequencing
-
Berlin, Germany
- +4 more
Jun 19, 2023
Psychosis, Schizophrenia, Schizoaffective Disorder Trial (Care Coordination, Individual Peer Support, Digital Outreach)
Not yet recruiting
- Psychosis
- +4 more
- Care Coordination
- +4 more
- (no location specified)
Oct 6, 2023
Seemingly Healthy, Genetic Predisposition to Disease Trial in Framingham, Jackson (Genomic Sequencing)
Enrolling by invitation
- Seemingly Healthy
- Genetic Predisposition to Disease
- Genomic Sequencing
-
Framingham, Massachusetts
- +1 more
Jun 15, 2022
Evaluating Disparities in Precision Oncology
Not yet recruiting
- Metastatic Cancer
- Advanced Cancer
- Social Determinants of Health and toxicity questionnaires
-
Indianapolis, IndianaIndiana University Health Melvin and Bren Simon Comprehensive Ca
Oct 7, 2023
Menstruation Trial (Hysteroscopy)
Not yet recruiting
- Menstruation
- Hysteroscopy
- (no location specified)
Jun 7, 2022
Early Anti-Retroviral Treatment in HIV- Infected Children
Active, not recruiting
- HIV Infections
- Blood samples collection
-
Bamako, Mali
- +5 more
Mar 13, 2023
Barriers and Facilitators of Parent-Child Communication in
Not yet recruiting
- Genetic Predisposition
- (no location specified)
May 5, 2023
COVID RESPONSE STUDY (COVRES)
Completed
- COVID-19
- Disease severity
-
Londonderry, United KingdomPersonalised Medicine Centre, School of Medicine, Ulster Univers
Sep 20, 2022
HIV Seropositivity Trial in Isingiro (Early CCLAD)
Completed
- HIV Seropositivity
- Early CCLAD
-
Isingiro, UgandaNakivale Refugee Settlement
May 20, 2022
HIV-1-infection, HIV, PD-L1 Gene Mutation Trial in Beijing (ASC22 1mg/kg, ASC22 2.5mg/kg, Antiretroviral Therapy)
Recruiting
- HIV-1-infection
- +2 more
- ASC22 1mg/kg
- +3 more
-
Beijing, Beijing, ChinaThe FifthMedical Center of the General Hospital of thePeoples Li
Jun 28, 2022
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Recruiting
- Recurrent Childhood Acute Myeloid Leukemia
- +17 more
-
Miami, FloridaNicklaus Children's Hospital
May 13, 2023
Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Tumors Trial in Melbourne
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- +3 more
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
May 17, 2023